• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
GPCRLigNet: rapid screening for GPCR active ligands using machine learning.GPCRLigNet:使用机器学习快速筛选 GPCR 活性配体。
J Comput Aided Mol Des. 2023 Mar;37(3):147-156. doi: 10.1007/s10822-023-00497-2. Epub 2023 Feb 25.
2
Development and validation of a novel protein-ligand fingerprint to mine chemogenomic space: application to G protein-coupled receptors and their ligands.一种用于挖掘化学基因组空间的新型蛋白质-配体指纹图谱的开发与验证:应用于G蛋白偶联受体及其配体
J Chem Inf Model. 2009 Apr;49(4):1049-62. doi: 10.1021/ci800447g.
3
Molecular interaction fingerprint approaches for GPCR drug discovery.用于G蛋白偶联受体(GPCR)药物发现的分子相互作用指纹方法。
Curr Opin Pharmacol. 2016 Oct;30:59-68. doi: 10.1016/j.coph.2016.07.007. Epub 2016 Jul 29.
4
Methods for Virtual Screening of GPCR Targets: Approaches and Challenges.G蛋白偶联受体(GPCR)靶点虚拟筛选方法:途径与挑战
Methods Mol Biol. 2018;1705:233-264. doi: 10.1007/978-1-4939-7465-8_11.
5
G Protein-Coupled Receptor-Ligand Pose and Functional Class Prediction.G 蛋白偶联受体-配体构象和功能分类预测。
Int J Mol Sci. 2024 Jun 22;25(13):6876. doi: 10.3390/ijms25136876.
6
Automated Inference of Chemical Discriminants of Biological Activity.生物活性化学判别因子的自动推断
Methods Mol Biol. 2018;1762:307-338. doi: 10.1007/978-1-4939-7756-7_16.
7
Docking Finds GPCR Ligands in Dark Chemical Matter.对接发现 GPCR 配体在黑暗的化学物质中。
J Med Chem. 2020 Jan 23;63(2):613-620. doi: 10.1021/acs.jmedchem.9b01560. Epub 2020 Jan 13.
8
DENVIS: Scalable and High-Throughput Virtual Screening Using Graph Neural Networks with Atomic and Surface Protein Pocket Features.DENVIS:使用具有原子和表面蛋白口袋特征的图神经网络进行可扩展的高通量虚拟筛选。
J Chem Inf Model. 2022 Oct 10;62(19):4642-4659. doi: 10.1021/acs.jcim.2c01057. Epub 2022 Sep 26.
9
Automated discovery of GPCR bioactive ligands.GPCR 生物活性配体的自动发现。
Curr Opin Struct Biol. 2019 Apr;55:17-24. doi: 10.1016/j.sbi.2019.02.011. Epub 2019 Mar 23.
10
Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification.基于结构的孤啡肽受体虚拟筛选:用于提高命中识别的混合对接和基于形状的方法。
J Chem Inf Model. 2014 Oct 27;54(10):2732-43. doi: 10.1021/ci500291a. Epub 2014 Sep 17.

引用本文的文献

1
Ligand-Induced Biased Activation of GPCRs: Recent Advances and New Directions from In Silico Approaches.G蛋白偶联受体的配体诱导偏向性激活:计算机模拟方法的最新进展与新方向
Molecules. 2025 Feb 25;30(5):1047. doi: 10.3390/molecules30051047.
2
AiGPro: a multi-tasks model for profiling of GPCRs for agonist and antagonist.AiGPro:一种用于G蛋白偶联受体激动剂和拮抗剂分析的多任务模型。
J Cheminform. 2025 Jan 29;17(1):12. doi: 10.1186/s13321-024-00945-7.
3
Leveraging Artificial Intelligence in GPCR Activation Studies: Computational Prediction Methods as Key Drivers of Knowledge.利用人工智能进行 G 蛋白偶联受体激活研究:计算预测方法作为知识的关键驱动力。
Methods Mol Biol. 2025;2870:183-220. doi: 10.1007/978-1-0716-4213-9_10.
4
G Protein-Coupled Receptor-Ligand Pose and Functional Class Prediction.G 蛋白偶联受体-配体构象和功能分类预测。
Int J Mol Sci. 2024 Jun 22;25(13):6876. doi: 10.3390/ijms25136876.
5
Keras/TensorFlow in Drug Design for Immunity Disorders.Keras/TensorFlow 在免疫紊乱药物设计中的应用。
Int J Mol Sci. 2023 Oct 9;24(19):15009. doi: 10.3390/ijms241915009.

本文引用的文献

1
Essential Dynamics Ensemble Docking for Structure-Based GPCR Drug Discovery.基于结构的GPCR药物发现中的基本动力学集成对接
Front Mol Biosci. 2022 Jun 29;9:879212. doi: 10.3389/fmolb.2022.879212. eCollection 2022.
2
Molecular Basis of Class B GPCR Selectivity for the Neuropeptides PACAP and VIP.B类G蛋白偶联受体对神经肽垂体腺苷酸环化酶激活肽(PACAP)和血管活性肠肽(VIP)选择性的分子基础
Front Mol Biosci. 2021 Mar 25;8:644644. doi: 10.3389/fmolb.2021.644644. eCollection 2021.
3
Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition.基于机器学习和人工智能的生物活性配体发现和 GPCR 配体识别方法。
Methods. 2020 Aug 1;180:89-110. doi: 10.1016/j.ymeth.2020.06.016. Epub 2020 Jul 6.
4
Pushing the Boundaries of Molecular Representation for Drug Discovery with the Graph Attention Mechanism.利用图注意力机制拓展药物发现中分子表示的边界。
J Med Chem. 2020 Aug 27;63(16):8749-8760. doi: 10.1021/acs.jmedchem.9b00959. Epub 2019 Aug 27.
5
Analyzing Learned Molecular Representations for Property Prediction.分析用于性质预测的学习分子表示。
J Chem Inf Model. 2019 Aug 26;59(8):3370-3388. doi: 10.1021/acs.jcim.9b00237. Epub 2019 Aug 13.
6
Targeting the PAC1 Receptor for Neurological and Metabolic Disorders.针对神经和代谢紊乱的 PAC1 受体。
Curr Top Med Chem. 2019;19(16):1399-1417. doi: 10.2174/1568026619666190709092647.
7
Prediction of GPCR-Ligand Binding Using Machine Learning Algorithms.使用机器学习算法预测GPCR-配体结合
Comput Math Methods Med. 2018 Jan 30;2018:6565241. doi: 10.1155/2018/6565241. eCollection 2018.
8
G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?G 蛋白偶联受体作为已批准药物的靶点:有多少个靶点和多少种药物?
Mol Pharmacol. 2018 Apr;93(4):251-258. doi: 10.1124/mol.117.111062. Epub 2018 Jan 3.
9
Exploring GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.利用片段分子轨道(FMO)方法探索G蛋白偶联受体(GPCR)与配体的相互作用。
Methods Mol Biol. 2018;1705:179-195. doi: 10.1007/978-1-4939-7465-8_8.
10
Rapid and accurate assessment of GPCR-ligand interactions Using the fragment molecular orbital-based density-functional tight-binding method.使用基于片段分子轨道的密度泛函紧束缚方法快速准确评估GPCR-配体相互作用
J Comput Chem. 2017 Sep 5;38(23):1987-1990. doi: 10.1002/jcc.24850. Epub 2017 Jul 4.

GPCRLigNet:使用机器学习快速筛选 GPCR 活性配体。

GPCRLigNet: rapid screening for GPCR active ligands using machine learning.

机构信息

Department of Chemistry, University of Vermont, Burlington, VT, 05405, USA.

Department of Industrial and Physical Pharmacy, Department of Chemistry, Purdue University, West Lafayette, IN, 47906, USA.

出版信息

J Comput Aided Mol Des. 2023 Mar;37(3):147-156. doi: 10.1007/s10822-023-00497-2. Epub 2023 Feb 25.

DOI:10.1007/s10822-023-00497-2
PMID:36840893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10379640/
Abstract

Molecules with bioactivity towards G protein-coupled receptors represent a subset of the vast space of small drug-like molecules. Here, we compare machine learning models, including dilated graph convolutional networks, that conduct binary classification to quickly identify molecules with activity towards G protein-coupled receptors. The models are trained and validated using a large set of over 600,000 active, inactive, and decoy compounds. The best performing machine learning model, dubbed GPCRLigNet, was a surprisingly simple feedforward dense neural network mapping from Morgan fingerprints to activity. Incorporation of GPCRLigNet into a high-throughput virtual screening workflow is demonstrated with molecular docking towards a particular G protein-coupled receptor, the pituitary adenylate cyclase-activating polypeptide receptor type 1. Through rigorous comparison of docking scores for molecules selected with and without using GPCRLigNet, we demonstrate an enrichment of potentially potent molecules using GPCRLigNet. This work provides a proof of principle that GPCRLigNet can effectively hone the chemical search space towards ligands with G protein-coupled receptor activity.

摘要

具有针对 G 蛋白偶联受体的生物活性的分子代表了大量类似药物小分子的一个子集。在这里,我们比较了机器学习模型,包括扩张图卷积网络,它们进行二进制分类,以快速识别针对 G 蛋白偶联受体具有活性的分子。该模型使用超过 60 万个活性、非活性和诱饵化合物的大型数据集进行训练和验证。表现最好的机器学习模型被称为 GPCRLigNet,它是一种从 Morgan 指纹映射到活性的简单前馈密集神经网络。通过将 GPCRLigNet 纳入针对特定 G 蛋白偶联受体——垂体腺苷酸环化酶激活多肽受体 1 的高通量虚拟筛选工作流程,证明了这一点。通过对使用和不使用 GPCRLigNet 选择的分子的对接评分进行严格比较,我们证明了使用 GPCRLigNet 可以富集潜在有效的分子。这项工作提供了一个原理证明,即 GPCRLigNet 可以有效地针对具有 G 蛋白偶联受体活性的配体优化化学搜索空间。